Back to Search
Start Over
Supplementary Table 2 from Impact of TP53 Mutations on Outcome in EGFR-Mutated Patients Treated with First-Line Tyrosine Kinase Inhibitors
- Publication Year :
- 2023
- Publisher :
- American Association for Cancer Research (AACR), 2023.
-
Abstract
- Relation of TP53 mutations and clinical characteristics of patients
Details
- Database :
- OpenAIRE
- Accession number :
- edsair.doi.dedup.....039484f724f298b67c10c5e59cad9947
- Full Text :
- https://doi.org/10.1158/1078-0432.22465238